Biotron Analysis

Biotron Ltd is a huge company with lots of money however when reviewing the latest financial year to previous years i have found some irregularities that could be very questionable.
Biotron is left with very little capital expenditure by the time the company takes into  account its accumulated losses. The capital left is $4,475,110 out of $32,548,656. This is just ridiculous if you ask me however i do understand that a lot of money is spent on research and research often requires a lot of experimentation which sometimes produces results.

When looking at the assets current and fixed assets the company seems to have lost half of its entire assets over a year. Whether they sold it off and i'm not finding where the money went or they put the assets into leasing. It wouldn't make sense if they put it into leasing because the liabilities have decreased by half from last year. Another very interesting point i noticed was that the company declared it would not pay a financial year dividend for 2013.

The company did lost around almost $3.1 million on a net decreased due to the money they are losing on research. The research of the current year has been very slow and the company has hit a very low point in its revenue cycle. It had major publicity for its BIT255 drug which is set to cure HIV and Hepatitis C however the research is still on going and this make shareholders a little worried about whether the vaccine will work. Currently there is on site trials of 3 month testing in Thailand.

The graph above shows the last three years on the share market . As you can see the shares have had a huge slump but are slowly regaining into 2014.
2012 was a big year for Biotron as the company announced that it found this BIT255 drug that could possibly cure HIV and Hepatitis C. It got major publicity and then after three years it came up with inconsistent results which thus resulted in a distrust of shareholders.


My questions and confusion come from three main areas

1. Where are all the fixed asset cost going?
2. Why is the company so low in the share market right now?
3. Why doesn't the company outsource some of its job to ensure the job gets done quicker by similar smaller companies and thus finding results quicker?

Biotron Ltd Competition

Despite being at the forefront in the technological world of developing drugs for specifically HIV and Hepatitis C, they do have competitors that are catching up to the research standard. Some of these companies include AbbVie who is another specific HIV drug researching company.They are located within the US and service the world including Australia. The industry is based on money and this is why they need results and thus also why Biotron is succeeding because they have been getting good significant results.

Biotron LTD

Hey guys,  i saw this awesome new wonder drug that will be coming onto the market soon and i thought its worth checking out. The company is at the forefront of the research and its actually an Australian company which is a first.
Below ive linked a few videos and articles that show the company in a medias light.

http://www.biotron.com.au/wp-content/uploads/2013/04/2013_Mar_Cosmos_Perilous-Journey.pdf

The current issue that biotron is having is funding and also the results to clear the clinical trials as a success

New beginnings

Today i started my new course and it was very daunting at first. It was all this amount of information that i wasnt ready for. I just came back from holidays and was so unprepared for the amount of information however in a small few hours i have become very organised and now can tackle this semester .

Coffee simply is the one defining thing keeping many of us going through the long nights. Its quite relaxing yet exhilarating when put to good use. So don't forget to your coffee in the morning.

Welcome to my blog on everything about my study addiction.  I hope you get something out of this and will know the signs of study addiction before it happens to you . Cest la vie